MAGE-3 Antigen (271-279), human CAS NO.160295-81-8

MAGE-3 Antigen (271-279), human CAS NO.160295-81-8

MAGE-3 Antigen (271-279), human  CAS NO.160295-81-8

MAGE-3 Antigen (271-279), human CAS NO.160295-81-8

MAGE-3 Antigen (271-279), human CAS NO.160295-81-8

MAGE-3 Antigen (271-279), human is a synthetic peptide corresponding to residues 271–279 of the human melanoma-associated antigen MAGE-3. This high-purity antigen is designed for research and diagnostic applications, particularly in immunology and cancer studies. It serves as a critical tool for T-cell stimulation, epitope mapping, and the development of targeted cancer immunotherapies.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
MAGE-3 Antigen (271-279), human
CAS NO.
160295-81-8
Appearance
White to off-white lyophilized powder
Molecular Formula
C53H79N13O10
Molecular Weight
 1058.3g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, 0.1 M acetic acid, or DMSO at a concentration of ≥ 1 mg/mL

Endotoxin< 1.0 EU/mg
Biological Activity
Recognized by HLA-A2-restricted cytotoxic T lymphocytes (CTLs) specific for MAGE-3
Storage Conditions
Store at -20°C to -80°C for long-term storage; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

The peptide acts as a human leukocyte antigen (HLA)-restricted epitope, primarily presented by HLA-A2 molecules on antigen-presenting cells. Upon presentation, it activates cytotoxic T-lymphocytes (CTLs) specific to MAGE-3-expressing tumors, triggering an immune response aimed at eliminating malignant cells. This mechanism underpins its utility in studying T-cell recognition and antitumor immunity.


2.PRODUCT INDICATIONS

This antigen is indicated for use in scientific research, including in vitro T-cell activation assays, immunotherapy development, and immunological studies targeting melanoma and other MAGE-3-positive cancers. It is also employed in diagnostic reagent development and vaccine research to evaluate immune responses against tumor-associated antigens.


3.CLINICAL EFFICACY OF PRODUCT

While primarily for research use, studies demonstrate that MAGE-3-derived peptides can induce specific CTL responses in preclinical models, supporting their potential in adoptive cell therapies and cancer vaccine platforms. Clinical trials involving MAGE-3 antigens have shown promise in eliciting antitumor immunity, highlighting its relevance in advancing personalized cancer treatments.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.